Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.23.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Balance at the beginning at Jun. 30, 2021 $ 20,010 $ 0 $ 151,584 $ (130,119) $ (1,455)
Balance at the beginning (In shares) at Jun. 30, 2021   480,688      
Share-based compensation 870   870    
Foreign currency translation gain 210       210
Net loss (18,208)     (18,208)  
Balance at end at Jun. 30, 2022 2,882 $ 0 152,454 (148,327) (1,245)
Balance at end (In shares) at Jun. 30, 2022   480,688      
Issuance of common stock and pre-funded warrants sold for cash, net of offering costs of $1,869 16,015 $ 0 16,015    
Issuance of common stock and pre-funded warrants sold for cash, net of offering costs of $1,869, Shares   1,037,520      
Exercise of pre-funded warrants, Shares   127,743      
Share-based compensation 452   452    
Foreign currency translation gain 415       415
Net loss (19,562)     (19,562)  
Balance at end at Jun. 30, 2023 $ 202 $ 0 $ 168,921 $ (167,889) $ (830)
Balance at end (In shares) at Jun. 30, 2023   1,645,951